Common variants in IL-1RN, IL-1β and TNF-α and the risk of ovarian cancer: a case control study
Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorp...
Saved in:
Published in | Central-European journal of immunology Vol. 42; no. 2; pp. 150 - 155 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Poland
Termedia Publishing House
01.01.2017
Polish Society of Experimental and Clinical Immunology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1
(-511C>T), IL-1RN VNTR, TNF-
(-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women.
Study subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1
(-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF-
-308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group.
The significant association between IL-1RN VNTR, IL1-
(-511), TNF-
(-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis. |
---|---|
AbstractList | Aim of the study: Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1 (-511C>T), IL-1RN VNTR, TNF- (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. Methods and results: Study subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1 (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF- -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. Conclusions: The significant association between IL-1RN VNTR, IL1- (-511), TNF- (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis. Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1 (-511C>T), IL-1RN VNTR, TNF- (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. Study subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1 (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF- -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. The significant association between IL-1RN VNTR, IL1- (-511), TNF- (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis. AIM OF THE STUDYSeveral studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1β (-511C>T), IL-1RN VNTR, TNF-α (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. METHODS AND RESULTSStudy subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1β (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF-α -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. CONCLUSIONSThe significant association between IL-1RN VNTR, IL1-β (-511), TNF-α (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis. |
Author | Mezlini, Amel Sghaier, Ikram Ahmed, Amira Ben Zidi, Sabrina Almawi, Wassim Ghazouani, Ezzeddine Loueslati, Besma Yacoubi |
AuthorAffiliation | 1 Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia 2 Laboratory of Immunology, Military Hospital of Tunis, Tunis, Tunisia 3 Salah Azeiz Oncology Institute, Tunis, Tunisia 4 Department of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain |
AuthorAffiliation_xml | – name: 4 Department of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain – name: 2 Laboratory of Immunology, Military Hospital of Tunis, Tunis, Tunisia – name: 1 Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia – name: 3 Salah Azeiz Oncology Institute, Tunis, Tunisia |
Author_xml | – sequence: 1 givenname: Amira Ben surname: Ahmed fullname: Ahmed, Amira Ben organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia – sequence: 2 givenname: Sabrina surname: Zidi fullname: Zidi, Sabrina organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia – sequence: 3 givenname: Ikram surname: Sghaier fullname: Sghaier, Ikram organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia – sequence: 4 givenname: Ezzeddine surname: Ghazouani fullname: Ghazouani, Ezzeddine organization: Laboratory of Immunology, Military Hospital of Tunis, Tunis, Tunisia – sequence: 5 givenname: Amel surname: Mezlini fullname: Mezlini, Amel organization: Salah Azeiz Oncology Institute, Tunis, Tunisia – sequence: 6 givenname: Wassim surname: Almawi fullname: Almawi, Wassim organization: Department of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain – sequence: 7 givenname: Besma Yacoubi surname: Loueslati fullname: Loueslati, Besma Yacoubi organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28860932$$D View this record in MEDLINE/PubMed |
BookMark | eNpdksluFDEQhlsoiCxw5oYsceFAT9pLe-EQCY0IjDQKEgpnq9pL0kO3HezuSHkseJA8E56ZEBFOVbL_-qrK_o-rgxCDq6rXuFm0GLNT4zb9gjRYLLiiLX9WHWHOWM0wYQclZ4TXVGFyWB3nvGkarrBUL6pDIiVvFCVHFSzjOMaAbiH1EKaM-oBW6xp_u3i_i_e_EQSLLi_O6_tfu3S6dij1-QeKHsV9GTIQjEsfEJQsO2RimFIcUJ5me_eyeu5hyO7VQzypvp9_ulx-qddfP6-WH9e1YVJMtWfSem4ajtvOEiE5qM4KqyzwTkLnvfGeNox1nHEGzFhoHZdKWGBOEtrSk2q159oIG32T-hHSnY7Q691BTFca0tSbwenOWpBtq1RBM-8a6S3lGAsChmNDXWGd7Vk3czc6a1zZB4Yn0Kc3ob_WV_FWt62gUooCePcASPHn7PKkxz4bNwwQXJyzxqo05FRyUqRv_5Nu4pxCeaqiIkKJMikvqtO9yqSYc3L-cRjc6K0V9NYKemsFvbNCqXjz7w6P-r9_T_8AMJGx5w |
CitedBy_id | crossref_primary_10_1016_j_gene_2022_146288 crossref_primary_10_1007_s00604_022_05595_w crossref_primary_10_1007_s11033_022_07297_1 crossref_primary_10_1007_s40487_018_0089_z crossref_primary_10_1177_2152656719860820 crossref_primary_10_1158_1055_9965_EPI_21_0139 crossref_primary_10_4081_oncol_2019_413 crossref_primary_10_1186_s12866_020_02072_3 crossref_primary_10_1155_2018_7569809 crossref_primary_10_3390_cancers13030564 crossref_primary_10_1111_1348_0421_12774 crossref_primary_10_1016_j_intimp_2022_108577 crossref_primary_10_3390_cancers15020360 crossref_primary_10_1016_j_genrep_2022_101539 crossref_primary_10_1111_imm_13486 |
ContentType | Journal Article |
Copyright | Copyright Termedia Publishing House 2017 Copyright: © 2017 Polish Society of Experimental and Clinical Immunology 2017 |
Copyright_xml | – notice: Copyright Termedia Publishing House 2017 – notice: Copyright: © 2017 Polish Society of Experimental and Clinical Immunology 2017 |
DBID | NPM AAYXX CITATION 3V. 7RV 7T5 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.5114/ceji.2017.69356 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database Immunology Abstracts ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1644-4124 |
EndPage | 155 |
ExternalDocumentID | oai_doaj_org_article_bdda855996b84fe08fd361172ac61c3e 10_5114_ceji_2017_69356 28860932 |
Genre | Journal Article |
GroupedDBID | --- 29B 2NK 2WC 3EA 3V. 53G 5GY 5VS 7RV 7X7 88E 8AO 8FE 8FH 8FI 8FJ ABDBF ABMXE ABUWG ACPRK ADBBV ADRAZ AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI BKEYQ BPHCQ BVXVI CCPQU DIK EOJEC FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IPNFZ KQ8 LK8 M1P M48 M7P NAPCQ NPM OBODZ OK1 P2P P6G PGMZT PIMPY PQQKQ PROAC PSQYO RIG RPM TR2 UKHRP Y2W AAYXX CITATION 7T5 7XB 8FK AZQEC DWQXO GNUQQ H94 K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c487t-f48df6c0615bd2786a9bd7d9da6b8abffcff3044b6464a4cda5e6897da4e82353 |
IEDL.DBID | RPM |
ISSN | 1426-3912 |
IngestDate | Mon Oct 28 19:36:39 EDT 2024 Tue Sep 17 20:46:38 EDT 2024 Fri Aug 16 10:21:23 EDT 2024 Thu Oct 10 16:00:43 EDT 2024 Fri Aug 23 01:08:30 EDT 2024 Sat Sep 28 08:07:22 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | interleukin-1 tumor necrosis factor ovarian cancer gene variants |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c487t-f48df6c0615bd2786a9bd7d9da6b8abffcff3044b6464a4cda5e6897da4e82353 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573887/ |
PMID | 28860932 |
PQID | 1927978556 |
PQPubID | 2028857 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_bdda855996b84fe08fd361172ac61c3e pubmedcentral_primary_oai_pubmedcentral_nih_gov_5573887 proquest_miscellaneous_1936163862 proquest_journals_1927978556 crossref_primary_10_5114_ceji_2017_69356 pubmed_primary_28860932 |
PublicationCentury | 2000 |
PublicationDate | 2017-01-01 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Poland |
PublicationPlace_xml | – name: Poland – name: Warsaw |
PublicationTitle | Central-European journal of immunology |
PublicationTitleAlternate | Cent Eur J Immunol |
PublicationYear | 2017 |
Publisher | Termedia Publishing House Polish Society of Experimental and Clinical Immunology |
Publisher_xml | – name: Termedia Publishing House – name: Polish Society of Experimental and Clinical Immunology |
References | 14633943 - Gut. 2003 Dec;52(12):1684-9 25113639 - Pathol Oncol Res. 2015 Apr;21(2):339-45 8188271 - Genomics. 1994 Jan 15;19(2):382-4 12445604 - J Soc Gynecol Investig. 2002 Nov-Dec;9(6):386-90 9710237 - Eur J Immunol. 1998 Aug;28(8):2598-602 11196666 - Genes Immun. 1999 Nov;1(2):164-5 22562260 - Int J Colorectal Dis. 2013 Mar;28(3):431-2 17141301 - Gynecol Oncol. 2007 Mar;104(3):680-5 12548511 - Liver Transpl. 2003 Feb;9(2):170-81 20144842 - Gynecol Oncol. 2010 May;117(2):366-72 20450741 - Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Mar;44(3):209-14 15581980 - Gynecol Oncol. 2004 Dec;95(3):672-9 12463079 - AORN J. 2002 Nov;76(5):792-802, 805-6; quiz 807-10 1492596 - J Biol Regul Homeost Agents. 1992 Jul-Sep;6(3):103-7 23049925 - PLoS One. 2012;7(9):e46017 10544444 - Transpl Immunol. 1999 Jun;7(2):127-8 24969564 - Tumour Biol. 2014 Oct;35(10):9693-9 22349527 - Cytokine. 2012 May;58(2):133-47 14504049 - Ann Oncol. 2003 Oct;14(10):1501-4 12209358 - Genes Immun. 2002 Sep;3(6):313-30 9096369 - Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9 1448359 - Nurs Clin North Am. 1992 Dec;27(4):835-45 14555214 - Biochem Pharmacol. 2003 Oct 15;66(8):1403-8 23704929 - PLoS One. 2013 May 21;8(5):e63654 9646173 - Int Rev Immunol. 1998;16(5-6):457-99 8598468 - J Immunol. 1996 Jan 1;156(1):238-45 20882404 - Breast Cancer Res Treat. 2011 Apr;126(3):763-70 21107607 - J Cancer Res Clin Oncol. 2011 Jun;137(6):947-52 11229684 - Lancet. 2001 Feb 17;357(9255):539-45 |
References_xml | |
SSID | ssj0069189 ssib008506718 |
Score | 2.170921 |
Snippet | Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to... Aim of the study: Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines... AIM OF THE STUDYSeveral studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 150 |
SubjectTerms | Alleles Clinical Immunology gene variants Genotype & phenotype Genotyping Health risk assessment Heterozygotes Inflammation Interleukin 1 Interleukin 1 receptors Ovarian cancer Polymerase chain reaction Tumor necrosis factor |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuiG8CBRmJAwdMk9ixHW6AWBWE9oBaqbdo_CWWQ1K1WyR-FvyQ_iZm7HTZRUhcOMVKnMR5nthv4skbxp5bl1RbQxQauYdQISThonWi65OxilZqIEdbLPXhsfp40p1spfqimLAiD1yAO3AhgCVZLO2sSrG2KUjd4LQLXjdexjz61v2WM0WWRDps5vd6AjYkJ8NrcD4Ssm_aIvKDZEMd-Ph1RSFe5pXuJeWx3pqfsoz_37jnnyGUW3PS4ha7OZNJ_qY8xG12LY532PWSXvL7XQb098c08m_oD1O4C1-N_MMn0Xxevszby58cxsCPlgtx-SMXkQ1yCjbnU-JTOY17souz1xywdB75HNvOsy7tPXa8eH_07lDMKRWER89kLZKyIWlPPMaF1lgNvQsm9AEQXnAp-ZRkrZTTSitQPkAXte1NABVtKzt5n-2N0xgfMq5cDzV455BSqBY7BiyiESWkztmmjhV7cQXkcFqUMwb0OAjzgTAfCPMhY16xtwT0phpJXucdaAjDbAjDvwyhYvtX3TTM7-H5gPzVoJ_c0T2ebQ7jG0TLIjDG6YLq4HVwGNJtxR6UXt20pLVW10hxK2Z2-nunqbtHxtWXrNLddUbiCP7ofzzbY3aD0CqffvbZ3vrsIj5BMrR2T7Pd_wIdWQZk priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest_Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIlLxZuUgozEgQOmSfwMFwSIVUFoD6iV9hb5WZZDUna3SPws-CH9Tcw42d0uQpwSxU48Go_H33gmM4Q8Ny6JurSRKcAeTISQmIvGMdkkbQR6amyOtpiq41PxaSZn44HbcgyrXOvErKhD7_GM_AiQiAaLR0r15vw7w6pR6F0dS2hcJzequlQo1Xq23U4xG5veehWAnFwSr4JdifGmqodUPwA5xJGP3-YY6KVfqYZjNesru1RO5v8vBPp3IOWVnWlym-yPkJK-HWTgDrkWu7vk5lBk8uc9YvEfkL6jP8AqxqAXOu_ox8-s-jJ9ma-Xv6ntAj2ZTtjlr3wLmJBiyDntE-2H16hH6Vi8phbulpGOEe40Z6e9T04nH07eH7OxsALzYJ-sWBImJOURzbhQa6Ns44IOTbDKGetS8inxUginhBJW-GBlVKbRwYpoai75A7LX9V18RKhwjS2tdw6AhahjaawBbkRuk3SmKmNBXqwZ2Z4P-TNasDuQ5y3yvEWet5nnBXmHjN50w8TX-UG_OGvHddS6EKzBLGlAqUgwXgpcVYDCrFeV5zDe4Xqa2nE1Ltut7BTk2aYZ1hE6R2wX-wvsA98BZaTqgjwcZnVDSW2MKgHoFkTvzPcOqbst3fxrztUtpeagxw_-T9Zjcgv5MBztHJK91eIiPgGws3JPs0T_AaBj_Ww priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access(OpenAccess) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCIkLory6UJCROHDASxI_wwVRxKogtAfUlXqz7NiGrVAC2y2iPwt-SH8TM05220V75BQrduLJ59c38XiGkOfGJ1EVLjIF3IOJEBLz0Xgm66SNwJ0al60tpupwJj4ey-PLcEADgKdbVTuMJzVbfBv_-nH-BgY88Ncx0AXxqoknczTS0mNVc6mukxsVngNCO74rXB9ds-nLLQaQLcfHK2GJYrwuq97vz7YXbixZ2bP_Njr6r1XllWVqcofcHvglfdt3iF1yLbZ3yc0-4uT5PeLwQEjX0p-gIqMFDJ239MMnVn6evszXiz_UtYEeTSfs4ndOAkGkaH9Ou0S7_jHaYFdZvKYOUqeRDubuNLuqvU9mk_dH7w7ZEGWBNaCsLFkSJiTVILXxodJGudoHHerglDfOp9SkxAshvBJKONEEJ6MytQ5ORFNxyR-QnbZr4x6hwteucI33wDJEFQvjDKARuUvSm7KII_JiBaT93jvTsKCEIOYWMbeIuc2Yj8gBAr0uhl6w841u8cUOg8r6EJxBl2kgqUhQXwpclUDJXKPKhkN9-6tmsqueZYHSalCdJdbxbJ0Ngwp3SlwbuzMsA--BmUlVI_Kwb9W1JJUxqgDWOyJ6o703RN3Maedfs-NuKTWHSf3R__i2x-QWotX_DdonO8vFWXwC_Gjpn-Z-_xfIgQ3J priority: 102 providerName: Scholars Portal |
Title | Common variants in IL-1RN, IL-1β and TNF-α and the risk of ovarian cancer: a case control study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28860932 https://www.proquest.com/docview/1927978556 https://search.proquest.com/docview/1936163862 https://pubmed.ncbi.nlm.nih.gov/PMC5573887 https://doaj.org/article/bdda855996b84fe08fd361172ac61c3e |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIiQuiDcLZWUkDhzw7ibxK9xo1VVBdFVVrbS3yM-yiCbVdovEz4If0t_EjJMsbMWJSxLFdjwaj-Nv7M9jQt5oG3k-MYFJwB6Mex-ZDdoyUUalOa7UmMS2mMnDM_5pLuZbRPR7YRJp39nFqP52MaoXXxK38vLCjXue2Pj4aF8IVUDnGG-TbTDQWy46hmBTf5YSQIZ0Dl4GQxEryixv4_sAzuBjF74ukN2lRrIsBJ5mlGstwcfPN0apFMz_Xwj0NpHyr5Fp-oDc7yAl_dCK_pBshfoRudseMvnjMTG4B6Sp6XfwipH0Qhc1_fiZZSezd-l-84ua2tPT2ZTd_EyPgAkpUs5pE2nTFqMOrWP5nhp4ugq0Y7jTFJ32CTmbHpzuH7LuYAXmwD9Zsci1j9IhmrE-V1qa0nrlS2-k1cbG6GIsJpxbySU33HkjgtSl8oYHnReieEp26qYOzwnltjQT46wFYMHzMNFGgzZCYaKwOpuEAXnbK7K6bONnVOB3oPorVH-F6q-S-gdkDxW9zoaBr9OLZnledc1fWe-NxihpICmPUF_0hcwAhRknM1dAfbt9M1Vdb7yqAMUq8JYF1vF6nQz9CBdHTB2aa8wD34GfkcwH5FnbqmtJeqsYELXR3huibqaA6aZY3Z2pvvjvki_JPVRRO-uzS3ZWy-vwCnDQyg7B-udqSO7sHcyOT4ZpNgGuR1wPU4_4DW_PCrk |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,12069,21401,24331,27937,27938,31732,31733,33757,33758,43323,43818,53805,53807 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYIL4rlbWMBIHDhgNg_HdrggQFRdKD2grtSb5Sd0D8nSdpH4WfBD9jcx46TtFiFOiWInHo3H9jf25BtCnisbeZGZwARgD8a9j8wGZVlVR6k4ntSYFG0xEaMT_nFWzfoNt2UfVrmeE9NE7VuHe-RHgEQkeDxVJd6cfWeYNQpPV_sUGlfJNeThQjuXs-1yimxscnuqAOKklHg5rEqsrPOio_oByMGPXDidY6CXfCXqErNZX1qlEpn_vxDo34GUl1am4W1yq4eU9G1nA3fIldDcJde7JJM_7xGD_4C0Df0BXjEGvdB5Q4_HLP8yeZmuF7-paTydTobs4le6BUxIMeSctpG23WvUoXUsXlMDd8tA-wh3mthp75OT4Yfp-xHrEyswB_7JikWufBQO0Yz1hVTC1NZLX3sjrDI2RhdjmXFuBRfccOdNFYSqpTc8qKKsygdkr2mbcEAot7XJjLMWgAUvQqaMAm2E0sTKqjwLA_JirUh91vFnaPA7UOcada5R5zrpfEDeoaI31ZD4Oj1oF191P4609d4oZEkDSXmE9qIvRQ4ozDiRuxLaO1x3k-5H41JvbWdAnm2KYRzh4YhpQnuOdeA7MBmJYkD2u17dSFIoJTIAugMid_p7R9Tdkmb-LXF1V5UsYR5_-H-xnpIbo-nnsR4fTz49IjdRJ902zyHZWy3Ow2MAPiv7JFn3H5uTAGI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgCMSG92OggJFYsMB52o7DDgqjFsqoQq1UsbH8pFNoMprOIMFfwYf0m7h2MkNnxKqrRIkTO77X8bnxybkIvRDa0yJTjnDAHoRa64l2QhNW-0rQsFKjIttixLcP6IdDdngu1Vck7Rs9TprvJ0kzPorcysmJSRc8sXTv0xZjVQmDI51Yn15GV1gQTV8L1IMQW_VvQQFaErPh5TAhkbLOi07lB9AGTY07HgeOV5XwumQhp1EhBIdIv1iZq6Kk__9w6Dqd8tz8NLyJviyerKOlfEvmM52YX2uijxd69FvoRo9a8ZuuyG10yTV30NUuj-XPu0iF30zaBv-AwDvwavC4wTu7JP88ehW3Z3-waizeHw3J2e-4C7ATB1Y7bj1uu8uwCQ44fY0V7J063JPocRTAvYcOhu_3t7ZJn7uBGAiBZsRTYT03ATBpW1SCq1rbytZWcS2U9t54X2aUak45VdRYxRwXdWUVdaIoWXkfbTRt4x4iTHWtMmW0BuxCC5cJJaCrXak80yLP3AC9XFhJTjqJDgmhTbCtDLaVwbYy2naA3gYrLosFbe14oJ1-lX03S22tEkGIDVpKPdTnbclzAHrK8NyUUN_mwgdkP-BPJQDlCgJyFup4vjwNQzWsv6jGtfNQBu4D7zteDNCDzmWWLVm43ABVK8600tTVM-AiUQ68d4lHF77yGbq2924od3dGHx-j66G3um9Mm2hjNp27J4C6ZvppHF9_AXTfKus |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Common+variants+in+IL-1RN%2C+IL-1%CE%B2+and+TNF-%CE%B1+and+the+risk+of+ovarian+cancer%3A+a+case+control+study&rft.jtitle=Central-European+journal+of+immunology&rft.au=Amira+Ben+Ahmed&rft.au=Sabrina+Zidi&rft.au=Ikram+Sghaier&rft.au=Ezzeddine+Ghazouani&rft.date=2017-01-01&rft.pub=Termedia+Publishing+House&rft.issn=1426-3912&rft.eissn=1644-4124&rft.volume=42&rft.issue=2&rft.spage=150&rft.epage=155&rft_id=info:doi/10.5114%2Fceji.2017.69356&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bdda855996b84fe08fd361172ac61c3e |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1426-3912&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1426-3912&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1426-3912&client=summon |